Related Experiment Video
Updated: May 17, 2026

07:45
"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
Published on: November 28, 2025
[Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma]
Rui Chen1, Tao Wei, Ming Zhang
1Department of Thyroid and Breast, West China Hospital of Sichuan University, Chengdu, China.
Summary
For papillary thyroid carcinoma (PTC) patients with clinically negative nodes (cN0), lateral neck dissection (LND) is recommended for males with advanced tumors or multiple positive central lymph nodes. Dissection should target levels III and IV, with consideration for levels II and V based on tumor location and metastasis patterns.
Area of Science:
- Oncology
- Surgical Pathology
- Head and Neck Surgery
Background:
- Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy.
- Accurate staging and understanding lymph node metastasis patterns are crucial for effective treatment planning in PTC.
- The role of lateral neck dissection (LND) in clinically node-negative (cN0) PTC patients remains a subject of investigation.
Purpose of the Study:
- To elucidate the patterns of lymph node spread in papillary thyroid carcinoma (PTC) patients presenting with clinically negative nodes (cN0).
- To identify predictive factors for lateral neck lymph node metastasis in cN0 PTC.
- To guide surgical decision-making regarding the extent of LND in cN0 PTC.
Main Methods:
- Retrospective analysis of 106 patients with cN0 PTC who underwent thyroidectomy and lateral neck dissection (LND) at West China Hospital.
- Analysis included patients who underwent LND of levels II-V or I-V.
- Data collected between April 2004 and August 2010.
Main Results:
- Lateral neck lymph node metastasis in cN0 PTC was significantly associated with male sex, T3/T4 tumor stage, tumor size > 1 cm, and ≥ 2 positive central lymph nodes.
- Level III (40.5%) was the most frequent metastatic site, followed by Level IV (35.3%) and Level II (15.5%).
- Metastasis patterns correlated with primary tumor location; Level II metastasis was associated with upper-site tumors and often accompanied Level III metastasis.
Conclusions:
- LND is recommended for cN0 PTC in males with T3/T4 lesions and ≥ 2 positive central lymph nodes, with dissection encompassing levels III and IV.
- Consider LND of Level II for tumors in the upper thyroid lobe or with concurrent Level III metastasis; consider Level V if Levels II, III, and IV are involved.
- LND is not advised for cN0 PTC with tumors < 1 cm, confined to the thyroid, and without central lymph node metastasis.

